Crown Bioscience Inc.
Crown Bioscience Inc. Announcing the 2017 Board of Directors Election Results
Dr. Guoliang Yu re-elected as the Chairman
TAIPEI, Taiwan, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE: ticker 6554) and a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research, has held an extraordinary general meeting and announced results of stockholder elections for the company's 2017 Board of Directors. Dr. Guoliang Yu was re-elected as Chairman of the Board.
The elected Board of Directors comprise global experts and industry leaders from venture capital, corporate management, biotechnology and corporate governance. The complete list of elected directors is as follows:
Dr. Guoliang Yu, Director, Chairman of Board, re-elected
Mr. Sandy Chau, Director, re-elected
Mr. Chen-Chi Kai, Director, re-elected
Dr. Hongbo Lu, Director, re-elected
Dr. Jo Shen, Independent Director, re-elected
Dr. George Lee, Independent Director, re-elected
Mr. Wu-Fu Chen, Director, newly-elected
Mr. Andrew Lin, Independent Director, newly-elected
Dr. Jean-Pierre Wery, Director, newly-elected
The newly elected Director Mr. Wu-Fu Chen received his Master of Electrical Engineering degree from University of Florida and later completed his Ph.D. in Computer Science at University of California, Berkeley. He began his entrepreneur journey from Silicon Valley and was named "The Top 10 Entrepreneur of 2000", "The Germinator", and "The Top 100 Venture Investors in the US of 2002". Mr. Wu currently served as the Chairman of Acorn Venture Capitals and is well known for his success in capital investments.
The newly elected Director Mr. Andrew Lin received his MBA degree from the University of Chicago and later completed a Master of Electrical and Computer Engineering degree at Massachusetts Institution of Technology. He is well recognized for his professional expertise in securities studies, investment banking, corporate management, and strategy consulting. Mr. Lin currently serves as the Chairman of Lotus Pharmaceutical and Independent Director of Fubon Life Insurance.
The newly elected Director Dr. Jean-Pierre Wery, is CEO of Crown Bioscience. Dr. Wery has been working for the company since 2008 and was appointed as CEO in 2016. He received his Ph.D. in Physics at Université de Liège and completed his postdoctoral studies at Purdue University.
The elected Board will serve a three year term. The three Independent Directors Jo Shen, George Lee, and Chun Lin will serve as the members of Audit and Compensation Committees. The shareholder voting participating rate is close to 70% and the major shareholders include OrbiMed Healthcare Fund Management, Lilly Asia Ventures, and Center Laboratories.
About Crown Bioscience Inc.
Crown Bioscience is a global drug discovery and development solutions company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research. With an extensive portfolio of relevant models and predictive tools, Crown Bioscience enables clients to deliver superior clinical candidates.
Crown Bioscience Inc.
Information om Nasdaq OMX
Følg pressemeddelelser fra Nasdaq OMX
Skriv dig op her og modtag pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Nasdaq OMX
Crown Bioscience Inc.22.3.2018 14:45 | pressemeddelelse
CBT Pharmaceuticals to Grow Immuno-Oncology Pipeline by License Agreement of CrownBio CTLA-4 Antibody
SEMAFO Inc.22.3.2018 12:01 | pressemeddelelse
SEMAFO: Construction of Boungou Mine 87% Complete
3Gtms21.3.2018 15:02 | pressemeddelelse
3Gtms Positioned in the Niche Players Quadrant of the Gartner Magic Quadrant for Transportation Management Systems
Addivant21.3.2018 14:39 | pressemeddelelse
Addivant Announces Price Increases on Hindered Amine Light Stablizers
VistaJet Ltd21.3.2018 14:19 | pressemeddelelse
VistaJet Connects Customers and Their Passions With the Global British Polo Day Tour
Boyden21.3.2018 06:04 | pressemeddelelse
Boyden Focuses on Expansion in Nordic Region
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum